X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA IPCA LABS ELDER PHARMA/
IPCA LABS
 
P/E (TTM) x -0.2 29.7 - View Chart
P/BV x 0.1 3.5 2.9% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 ELDER PHARMA   IPCA LABS
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
IPCA LABS
Mar-18
ELDER PHARMA/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs380695 54.6%   
Low Rs188400 47.0%   
Sales per share (Unadj.) Rs491.2260.2 188.8%  
Earnings per share (Unadj.) Rs-3.219.0 -16.8%  
Cash flow per share (Unadj.) Rs14.433.1 43.6%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs376.5213.0 176.7%  
Shares outstanding (eoy) m20.54126.20 16.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.62.1 27.5%   
Avg P/E ratio x-89.328.9 -309.2%  
P/CF ratio (eoy) x19.716.6 119.0%  
Price / Book Value ratio x0.82.6 29.3%  
Dividend payout %05.3 0.0%   
Avg Mkt Cap Rs m5,83369,120 8.4%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m2,1797,359 29.6%   
Avg. sales/employee Rs ThNM2,477.4-  
Avg. wages/employee Rs ThNM555.2-  
Avg. net profit/employee Rs ThNM180.6-  
INCOME DATA
Net Sales Rs m10,08932,836 30.7%  
Other income Rs m257418 61.4%   
Total revenues Rs m10,34633,254 31.1%   
Gross profit Rs m-7924,505 -17.6%  
Depreciation Rs m3611,777 20.3%   
Interest Rs m2,756240 1,147.5%   
Profit before tax Rs m-3,6532,905 -125.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125511 24.5%   
Profit after tax Rs m-652,394 -2.7%  
Gross profit margin %-7.813.7 -57.2%  
Effective tax rate %-3.417.6 -19.5%   
Net profit margin %-0.67.3 -8.9%  
BALANCE SHEET DATA
Current assets Rs m9,24019,455 47.5%   
Current liabilities Rs m9,99810,076 99.2%   
Net working cap to sales %-7.528.6 -26.3%  
Current ratio x0.91.9 47.9%  
Inventory Days Days4698 47.3%  
Debtors Days Days6067 89.5%  
Net fixed assets Rs m10,12420,260 50.0%   
Share capital Rs m206252 81.5%   
"Free" reserves Rs m5,58226,633 21.0%   
Net worth Rs m7,73426,886 28.8%   
Long term debt Rs m4,8892,340 208.9%   
Total assets Rs m22,88241,173 55.6%  
Interest coverage x-0.313.1 -2.5%   
Debt to equity ratio x0.60.1 726.3%  
Sales to assets ratio x0.40.8 55.3%   
Return on assets %11.86.4 183.8%  
Return on equity %-0.88.9 -9.5%  
Return on capital %22.310.8 207.3%  
Exports to sales %3.047.6 6.4%   
Imports to sales %0.414.9 2.9%   
Exports (fob) Rs m30715,642 2.0%   
Imports (cif) Rs m434,884 0.9%   
Fx inflow Rs m30715,642 2.0%   
Fx outflow Rs m1254,884 2.6%   
Net fx Rs m18110,759 1.7%   
CASH FLOW
From Operations Rs m11,7543,411 344.6%  
From Investments Rs m-561-1,354 41.4%  
From Financial Activity Rs m-6,762-1,304 518.5%  
Net Cashflow Rs m4,432753 588.4%  

Share Holding

Indian Promoters % 39.6 45.9 86.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 11.4 65.8%  
FIIs % 16.8 25.3 66.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 17.4 207.5%  
Shareholders   16,479 36,892 44.7%  
Pledged promoter(s) holding % 77.6 2.1 3,624.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   TTK HEALTHCARE  ALEMBIC LTD  WYETH LTD  AJANTA PHARMA  SUVEN LIFE  

Compare ELDER PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Lower, Realty and FMCG Stocks Witness Selling(Closing)

After opening the day on a positive note, share markets in India witnessed volatile trading activity and ended in red.

Related Views on News

IPCA LABS Announces Quarterly Results (1QFY19); Net Profit Down 423.6% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, IPCA LABS has posted a net profit of Rs 655 m (down 423.6% YoY). Sales on the other hand came in at Rs 9 bn (up 19.8% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (4QFY18); Net Profit Up 15.6% (Quarterly Result Update)

May 30, 2018 | Updated on May 30, 2018

For the quarter ended March 2018, IPCA LABS has posted a net profit of Rs 513 m (up 15.6% YoY). Sales on the other hand came in at Rs 8 bn (up 17.6% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Hurricanes Threaten Oil Spike, but the Saudis are Selling...(Vivek Kaul's Diary)

Sep 6, 2018

Oil prices are rising and could go even more higher amid rising tensions in Middle East.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS